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Abstract
OBJECTIVE—We examined practices of obstetrician-gynecologists regarding nonvaccine-related 
public health recommendations during the 2009 H1N1 influenza pandemic.
STUDY DESIGN—From February to May 2010, a survey was sent to a random sample of 
members of the American College of Obstetricians and Gynecologists involved in obstetric care.
RESULTS—Obstetrician-gynecologists varied in their adherence to 2009 H1N1 influenza public 
health recommendations. Nearly all reported prescribing antiviral medications to pregnant women 
with suspected influenza. Most obstetrician-gynecologists reported using preventive practices in 
the outpatient setting to reduce exposure of well patients to ill ones. A wide range of responses 
was provided regarding postpartum infection control practices, suggesting lack of awareness of, 
disagreement with, or difficulty adhering to these recommendations.
CONCLUSION—Obstetrician-gynecologists reported that they adhered to some 
recommendations related to 2009 H1N1 influenza, but not to others. These data provide insight 
into strategies for development and dissemination of recommendations in a future pandemic.
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Pregnant women have been shown to be at increased risk for influenza-associated 
complications during influenza seasons and previous influenza pandemics.1 During the 
influenza A(H1N1)pdm09 (2009 H1N1) pandemic, pregnant women were 4 times more 
likely to be hospitalized than persons in the general population,2 and accounted for a 
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disproportionate number of deaths.3 Treatment within the first 2 days after symptom onset 
was associated with a lower risk of admission to an intensive care unit and death.3
Vaccination is the best way to prevent influenza and its complications among pregnant 
women4 and infants less than 6 months of age,5–8 and results regarding attitudes and 
practices of obstetrician-gynecologists regarding influenza vaccination during the 2009 
H1N1 pandemic were published recently.9 However, 2009 H1N1 vaccine did not become 
available until several months after the first cases of 2009 H1N1 were recognized in the 
United States. Before that time, non-pharmaceutical interventions, infection control 
guidelines, and antiviral treatment and chemoprophylaxis were the primary strategies to 
prevent influenza-associated complications.
During the 2009 H1N1 pandemic, public health recommendations specific to pregnant 
women regarding nonpharmaceutical interventions, infection control in the inpatient and 
outpatient settings, influenza diagnostic testing, antiviral treatment and prophylaxis, as well 
as those related to influenza vaccine against seasonal and 2009 H1N1 influenza were 
developed by the Centers for Disease Control and Prevention (CDC).10 Guidelines on 
nonpharmaceutical interventions for prevention of influenza included recommendations for 
frequent hand hygiene and respiratory etiquette, and avoidance of ill people.11 Within health 
care outpatient settings, clinicians were advised to identify and isolate ill patients to prevent 
exposure to well patients and to provide facemasks for ill patients.12 In the hospital during 
labor and delivery and postpartum, clinicians were advised to limit visitors (ie, allow the 
presence only of healthy adults who are necessary for the woman’s emotional well-being 
and care in labor and delivery), have ill mothers wear facemasks during labor and delivery, 
temporarily separate ill mothers from their healthy newborns, and have the mother express 
breast milk for infant feeding by a healthy caregiver.13 CDC recommended empiric 
treatment with oseltamivir of pregnant women who presented with suspected or confirmed 
influenza, and emphasized that treatment decisions should be based on suspicion of 
influenza, rather than on diagnostic testing, given the low sensitivity of rapid influenza 
diagnostic tests and the time necessary for more definitive testing to be completed. CDC 
guidelines during the pandemic also stated that chemoprophylaxis could be considered for 
pregnant women who had close contact with a person with suspected or confirmed 
influenza.14
These public health recommendations specific to pregnant women were vigorously 
communicated to health care providers, including obstetrician-gynecologists, through close 
collaborative efforts with key partners such as the American College of Obstetricians and 
Gynecologists (ACOG) and a wide variety of mechanisms (eg, internet, webinars, emails, 
publications).10 The practices of obstetrician-gynecologists in the United States regarding 
nonvaccine-related public health recommendations during the pandemic have not yet been 
examined. In this study, we present results of a survey of ACOG members who provided 
obstetric care regarding their practices related to public health recommendations during the 
2009 H1N1 pandemic (excluding those related to vaccines).
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Materials and Methods
To determine practices of obstetrician-gynecologists regarding strategies to prevent influenza 
used in outpatient and inpatient settings, influenza diagnostic testing, and antiviral treatment 
and prophylaxis, we mailed a survey to a nationally representative sample of 3116 
obstetrician-gynecologists selected randomly from a sample of 33,685 practicing 
obstetrician-gynecologists who were Fellows or Junior Fellows of ACOG. Obstetrician-
gynecologists currently involved in obstetric care were eligible to participate; others were 
asked to return the survey without responding. Obstetrician-gynecologists received the 
survey, a cover letter, and a prepaid envelope; participants were not offered an incentive to 
participate. The first mailing was sent in February 2010, with second, third, and fourth 
mailings sent to nonrespondents at 4- to 5-week intervals. The survey consisted of 33 
questions about basic demographics of respondents and their patients, and practices 
regarding public health recommendations for pregnant women regarding influenza. Five 
weeks after the fourth mailing, a short follow-up survey with 6 questions was sent to 
nonrespondents to assess nonresponse bias by comparing the responses of respondents and 
nonrespondents.
Analyses were performed using SAS version 9.1 (SAS Institute Inc., Cary, NC) and SPSS 
version 16.0 (SPSS Inc., Chicago, IL). We calculated frequencies of responses to each 
survey question, excluding nonresponses from the denominators for each question. To 
compare differences in responses for the 2008–2009 and 2009–2010 influenza seasons, 2-
sided χ2 tests and a significance level of P ≤ .05 were used.
This project was reviewed for human subject concerns by CDC and ACOG and was deemed 
to be exempt from institutional review board review.
Results
Of the 3116 surveys mailed, 20 were returned as undeliverable. Among the obstetrician-
gynecologists who received the survey, 2 refused to participate and 1310 returned the survey, 
for a response rate of 42.3% (1310/3096). Of those providers who returned the surveys, 437 
(33.4%) responded that they did not provide obstetric care during the 2009–2010 influenza 
season; thus, responses from 873 eligible participants are included in this analysis.
The mean age of respondents was 48.9 years, mean duration of clinical practice was 16.7 
years, and 51.1% of respondents were female (Table 1). Nearly half of the respondents 
practiced in a group obstetrician-gynecologist setting, and nearly all respondents considered 
primary care/preventive medicine as either a very important or important part of their 
practice. Respondents were asked to estimate the proportion of their patients eligible for 
Medicaid and the mean was 33.4%. Respondents were also asked about the race-ethnicity of 
patients in their practices; responses showed that over half of patients were non-Hispanic 
white (Table 1).
Respondents reported using several preventive practices in outpatient obstetric settings more 
often during the 2009–2010 season than during the 2008–2009 influenza season. More than 
half of providers reported rescheduling routine appointments for pregnant patients with 
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influenza-like illness (ILI) until they were healthy, questioning patients about recent ILI 
symptoms so that those with suspected ILI could be separated from healthy women, and 
asking patients with ILI to wear facemasks in the waiting area during the 2009–2010 season 
(Table 2). Obstetrician-gynecologists also reported discussing preventive measures with 
pregnant patients more often during the 2009–2010 season than during the 2008–2009 
season, including social distancing (eg, minimizing contact with sick individuals), frequent 
handwashing, cough etiquette, early symptom recognition, and prompt treatment of fever 
with fever-reducing medications (Table 2).
With regard to infection control during labor and delivery (Table 3), nearly 80% of 
obstetrician-gynecologists reported that they questioned patients about the presence of flu-
like symptoms “most of the time,” and nearly all reported separating ill from healthy 
patients during labor and delivery. However, fewer respondents reported asking ill patients to 
wear a surgical mask during labor and delivery or required ill mothers to wear a mask before 
holding their healthy newborns immediately after delivery “most of the time.” More than 
80% of responding obstetrician-gynecologists reported limiting visitors to healthy persons 
who were necessary for the patient’s emotional well-being (Table 3).
When asked about postpartum infection control guidelines (Table 3), about 40% of 
obstetrician-gynecologists reported rarely or never separating ill mothers from their healthy 
newborns immediately after delivery. More than half of obstetrician-gynecologists reported 
allowing rooming-in between a convalescent mother and her healthy newborn after delivery 
under droplet precautions either most of the time or sometimes. “Most of the time” was 
selected by more than 10% of obstetrician-gynecologists in response to several different 
postpartum options, including allowing rooming-in between a convalescent mother and her 
healthy newborn after delivery with no precautions, separating a healthy newborn from an ill 
mother and moving the infant to the well infant nursery in proximity to other newborns, and 
separating a healthy newborn from an ill mother and moving the infant to the well infant 
nursery but apart from other newborns.
The majority of obstetrician-gynecologists reported that they encouraged ill mothers to wear 
a facemask while directly breastfeeding their healthy newborns either most of the time or 
sometimes (Table 3). Obstetrician-gynecologists also frequently reported encouraging 
mothers to wash their hands with soap and water before breastfeeding and to observe 
respiratory etiquette guidelines. Obstetrician-gynecologists less commonly reported that they 
encouraged ill mothers to express breast milk to enable a well person to feed their infant 
either most of the time or sometimes. When asked about influenza diagnostic testing 
practices (Table 4), more than half of obstetrician-gynecologists reported relying on clinical 
diagnosis, although about a third reported using rapid influenza diagnostic testing for a 
pregnant woman presenting with symptoms of influenza. More than half said that they were 
less likely to or would not prescribe antiviral medications to a patient with negative rapid test 
results (Table 4). Rapid tests were used more commonly for pregnant women with 
underlying conditions than for healthy pregnant women. Nearly all obstetrician-
gynecologists reported that they prescribed antiviral treatment to pregnant women based on 
clinical evaluation; however, 8.7% reported that they would treat low-risk pregnant women 
only after test results confirmed influenza (Table 5). Obstetrician-gynecologists were 
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significantly less likely to base their treatment decisions on test results in high-risk women 
(women with underlying conditions in addition to pregnancy). Most obstetrician-
gynecologists reported having no or only slight concerns about the safety of antiviral 
medications for the pregnant woman or her fetus. Most obstetrician-gynecologists did not 
recommend chemoprophylaxis for high- or low-risk women with a possible exposure at a 
public event. The majority of obstetrician-gynecologists reported offering antiviral 
prophylaxis to a patient with a household member ill with confirmed or suspected 2009 
H1N1 influenza, to a patient who provides care to patients and has an exposure, and to a 
teacher with an exposure in the elementary school or day care setting. Obstetrician-
gynecologists reported being significantly more likely to offer antiviral chemoprophylaxis to 
a high-risk patient than a low-risk patient.
A total of 202 nonrespondents returned the short follow-up survey. Although these 
obstetrician-gynecologists were similar with regard to the number of years in clinical 
practice and the percentage of their pregnant patients that were eligible for Medicaid, some 
differences were observed between respondents who completed the full survey and those 
that only completed the short follow-up survey. Specifically, those completing the short 
follow-up survey were less likely to question arriving patients about recent symptoms of 
influenza and to separate women with suspected influenza from those that were healthy (P 
= .001). Those completing only the short follow-up survey were also less likely to ask 
patients with influenza-like illness to wear facemasks in the waiting area (P = .001) and were 
more likely to report concern about the safety of antiviral medications (P < .001).
Comment
This study examines practices of US obstetrician-gynecologists related to public health 
recommendations during the first influenza pandemic of the 21st century. Obstetrician-
gynecologists frequently reported that their practices had changed from the 2008–2009 
influenza season to the 2009–2010 season, suggesting an uptake of public health 
recommendations during the pandemic. In some cases, nearly all obstetrician-gynecologists 
reported practices consistent with CDC guidelines; for example, more than 90% of 
obstetrician-gynecologists reported that they prescribed antiviral medications for pregnant 
women with symptoms of influenza. However, practices related to other public health 
recommendations were more disparate. Although most obstetrician-gynecologists reported 
preventive practices in the outpatient setting consistent with those recommended by CDC 
(ie, questioning patients arriving to the clinic about recent ILI symptoms and separating 
those with suspected ILI from those that are healthy, and asking patients with ILI to wear 
facemasks in the waiting area), a notable proportion did not report these practices, and 
pregnant women in these facilities might have been at risk of exposure to influenza in the 
healthcare setting. A wide range of responses was provided to questions regarding infection 
control in the postpartum setting, with most obstetrician-gynecologists not reporting 
practices consistent with those recommended by CDC (especially those related to contact 
between an ill mother and well newborn). Despite data that showed that rapid influenza 
diagnostic testing had low sensitivity for 2009 H1N1,15–18 these tests were used by one-third 
of obstetrician-gynecologists for a women presenting with symptoms of influenza, and 
obstetrician-gynecologists said that they were less inclined to prescribe antiviral medications 
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when a rapid test was negative. The reasons for the lack of adherence to CDC 
recommendations are unclear. These may include lack of awareness or disagreement with 
recommendations or possibly that certain recommendations might be more difficult to 
implement than others.
In April of 2008, CDC held a meeting of experts and partners to plan for a future influenza 
pandemic. Several issues were discussed at this meeting,19 including nonpharmaceutical 
interventions, infection control, antiviral treatment and chemoprophylaxis, and influenza 
vaccines. Discussion of these critical issues with experts and partners (including 
representatives from ACOG) in a prepandemic setting might have facilitated their 
acceptance among obstetrician-gynecologists. Issues related to intrapartum and postpartum 
care of the ill pregnant woman were not discussed at this meeting, and these 
recommendations proved to be some of the more controversial and difficult to implement 
during the pandemic.20 Based on input received on the recommendations on intrapartum and 
postpartum care initially released, CDC developed revised recommendations that were 
released later in the 2009–2010 season. Changes in recommendations might be responsible 
for some of the differences observed between recommendations and reported practices.
The finding that obstetrician-gynecologists’ practices related to antiviral treatment were 
consistent with those recommended by CDC is encouraging, given that these 
recommendations for treatment of pregnant women with suspected or confirmed 2009 H1N1 
influenza were substantially different from those in place before the emergence of 2009 
H1N121 and the fact that early antiviral treatment of 2009 H1N1 was associated with a lower 
chance of severe illness.3 The reasons that obstetrician-gynecologists adhered to these 
changes are unknown, especially given that, similar to other medications,22 data on the 
safety of these medications during pregnancy available before and during the pandemic were 
limited.19 However, the finding that more than one-quarter of respondents had observed 
pregnant women with pneumonia requiring intensive care and 5% had observed deaths in 
pregnant women that they attributed to influenza9 likely played a role. In addition, the media 
coverage related to 2009 H1N1 influenza and pregnancy as a specific risk factor for severe 
complications10 also probably had an impact. Obstetrician-gynecologists attitudes toward 
use of antiviral medications during pregnancy were also positive, with most obstetrician-
gynecologists reporting that they were either not concerned or only slightly concerned about 
the safety of antiviral medications for the pregnant woman and her fetus.
Many obstetrician-gynecologists reported infection control practices, especially those in the 
inpatient intrapartum and postpartum setting, that varied widely and differed from CDC 
recommendations. A possible reason for this finding is that decisions regarding infection 
control might have been the responsibility of other professionals (eg, hospital infection 
control specialists, pediatricians, neonatologists), and thus, obstetrician-gynecologists might 
have been less familiar with these issues. The large percentage of “unsure” responses to 
questions about postpartum care and infant feeding is consistent with this possibility. 
However, a survey of neonatal intensive care directors in US hospitals regarding infection 
control practices for influenza in mother and newborn units identified a similar wide 
variation in practices.20
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This study has several limitations. The response rate to our survey was low: physicians are 
typically a difficult group to survey; however, our response rate was somewhat higher than 
those reported in previous surveys of random samples of general ACOG members.23 It is 
possible that respondents might differ from nonrespondents, although our nonresponse bias 
analysis did not suggest differences in a limited set of variables. The characteristics of our 
survey respondents were similar to those of US obstetrician-gynecologists,24 and the 
characteristics of their patients, as reported by the respondent obstetrician-gynecologists, 
were similar to those of US women giving births.25 However, based on results from a short 
follow-up survey sent to nonrespondents to the full survey, respondents might differ from 
nonrespondents in responses to some questions. In addition, the full survey was conducted in 
February–May 2010, at a time when the 2009 H1N1 vaccine was widely available and the 
main focus of influenza prevention efforts; thus, obstetrician-gynecologists might have been 
more likely to report discussion and implementation of nonpharmaceutical interventions 
earlier in the pandemic, before the vaccine became available. Practices are self-reported and 
respondents might provide responses that that they think are “correct,” rather than reflecting 
their true practices. However, this analysis showed important differences between certain 
public health recommendations and reported practices by obstetrician-gynecologists.
These data provide insight that might be helpful in the development and dissemination of 
guidance in a future influenza pandemic or other public health emergencies. These results 
suggest that seeking input in advance from key experts, partners, and practicing health care 
providers regarding recommendations for pregnant women is likely to be helpful. This input 
can be used to modify recommendations when appropriate and to identify recommendations 
for which additional efforts at dissemination may be necessary.
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TABLE 1
Characteristics of obstetrician-gynecologists who responded to the survey (n = 873)
Characteristics
Percentagea or
mean (range)
Sex, %
  Female 51.1
  Male 48.9
Average age, y 48.9 (29.7–84.6)
Average years in practice, y 16.7 (0.5–52)
Type of practice, %
  Group obstetrician-gynecologist practice 48.1
  Solo practice 16.4
  Multispecialty group 12.4
  University full-time faculty and practice 11.2
  Other 11.9
Consider primary care/preventive medicine an important part of practice, %
  Very important 45.8
  Important 49.4
  Not important 3.8
Average estimated % of patients eligible for Medicaid 33.4
Average estimated % of patients of certain race/ethnicity
  Non-Hispanic white 54.9
  Non-Hispanic black 15.2
  Hispanic 17.8
  Asian/Pacific Islander 5.3
  Native American 1.3
  Multiracial 2.6
  Other 1.0
aNumbers might not add to 100% because of rounding.
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TABLE 2
US obstetrician-gynecologists’ preventive practices, 2008–09 and 2009–10 seasons
Practices
2008–09 influenza
season, %
2009–10 influenza
season, % P value
Preventive practices used in outpatient settings
  Calling scheduled patients before appointment to ask about recent symptoms of ILI   2.1   4.4 < .05
  Referring pregnant patients with ILI symptoms to primary care provider for treatment 34.9 40.6 NS
  Rescheduling routine appointments for pregnant patients with ILI until they are 
healthy
30.7 51.2 < .0001
  Questioning arriving patients about recent ILI symptoms and separating those with 
suspected ILI from those that are healthy
35.9 65.5 < .0001
  Asking patients with ILI to wear facemasks in waiting area 28.0 59.6 < .0001
Always/frequently discuss specific preventive measures with pregnant women
    Discuss social distancing (eg, minimizing contact with ill individuals, avoiding 
crowded public gatherings)
58.0 79.2 < .0001
    Promote frequent hand washing 63.0 87.6 < .0001
    Discuss cough etiquette 43.7 62.7 < .0001
    Discuss early symptom recognition 51.7 76.6 < .0001
    Discuss prompt treatment of fever with fever-reducing medicines 57.7 75.9 < .0001
ILI, influenza like illness.
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TABLE 3
US obstetrician-gynecologists’ practices, inpatient settings, 2009–10 influenza season
Practicesa
Most of the
time Sometimes
Rarely or
never Unsure
Labor and delivery
  Questioning patients about recent flu-like symptoms 79.4% 12.7% 3.1% 4.8%
  Isolating ill patients from healthy patients during labor and delivery 91.6% 4.5% 2.1% 1.9%
  Asking ill patients to wear a surgical mask during labor and delivery 73.9% 9.8% 10.5% 5.7%
  Requiring ill mothers to wear a surgical mask before holding their healthy newborns 
immediately after delivery
57.7% 12.2% 20.2% 9.8%
  Limiting visitors to healthy persons who are necessary for the patient’s emotional well-
being and care
81.6% 10.4% 5.5% 2.5%
Postpartum
  Separating ill mother from her healthy newborn immediately after delivery 23.6% 16.9% 40.8% 18.7%
  Rooming-in between convalescent mother and her healthy newborn after delivery with 
no precautions
18.7% 14.2% 39.1% 28.1%
  Rooming-in between convalescent mother and her healthy newborn after delivery under 
droplet precautions
31.5% 22.5% 14.8% 31.1%
  Healthy newborn is separated from ill mother and moved to well infant nursery in 
proximity to other newborns
13.7% 12.4% 36.9% 37.0%
  Healthy newborn is separated from ill mother and moved to well infant nursery but 
apart from other newborns
15.2% 15.2% 29.3% 40.4%
  Healthy newborn is separated from ill mother and moved to special care nursery 9.3% 9.7% 43.1% 38.0%
  Healthy newborn is separated from ill mother and moved to NICU 6.2% 6.1% 50.9% 36.8%
Infant feeding
  Discouraging ill mothers from breastfeeding their healthy newborns (directly or via 
expressed milk)
6.5% 7.5% 63.8% 22.2%
  Encouraging ill mothers to express breast milk to enable a well person to feed their 
infant
19.4% 19.3% 32.1% 29.3%
  Encouraging ill mothers to wear a face mask while directly breastfeeding their healthy 
newborns
43.9% 19.0% 14.1% 23.0%
  Encouraging ill mothers to wash their hands with soap and water before breastfeeding 75.0% 7.0% 3.0% 15.1%
  Encouraging ill mothers to observe respiratory etiquette guidelines 69.4% 10.9% 3.1% 16.6%
NICU, neonatal intensive care unit.
a
For women with suspected or confirmed influenza-like illness.
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TABLE 4
US obstetrician-gynecologists’ practices: influenza diagnostic testing
Practices %
Diagnostic test most likely to use for pregnant patient presenting with fever (>100° F) and cough and/or sore throat
  Rapid antigen test 33.2
  DFA 2.0
  RT PCR for seasonal flu 7.8
  RT PCR for H1N1 14.9
  Viral culture 4.8
  IgG and IgM 2.7
  Clinical diagnosis 55.3
Interpreting on-site rapid antigen testing for influenza
  With a negative test result, I would not prescribe antivirals 9.3
  With a negative test result, I am less inclined to prescribe antivirals 44.0
  I do not use a negative test result to make a decision about prescribing antivirals 46.8
Always or frequently ordering rapid influenza diagnostic test for suspected influenza-like illness in specific groups of pregnant patients
  Healthy pregnant women 29.1
  Pregnant patients with underlying chronic condition 40.7
  Pregnant patients with prepregnancy obesity 31.9
DFA, data for analysis; IgG, immunoglobulin G; IgM, immunoglobulin M; PCR, polymerase chain reaction; RT, room temperature.
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TABLE 5
US obstetrician-gynecologists’ attitudes and practices: antiviral medications
Attitudes and practices
Low-risk
women, %
High-risk
women, % P value
Practice of prescribing antivirals for pregnant women with influenza-like illness symptoms
  Prescribed based solely on clinical evaluation 61.1 63.9 NS
  Perform clinical evaluation and testing but prescribed before test results available 28.0 30.5 NS
  Prescribed only after test results confirm influenza   8.7   3.3 < .0001
Concerns about the safety of antivirals for pregnant woman and/or her fetus
  Very concerned   3.1   3.7 NS
  Concerned   6.8   7.5 NS
  Slightly concerned 31.2 28.1 NS
  Not concerned 59.0 60.8 NS
Offering antiviral chemoprophylaxis against 2009 H1N1 influenza to specific groups of pregnant 
patients
  Patient concerned about possible exposure while attending a public event 15.0 31.6 < .0001
  Patient whose household member has confirmed 2009 H1N1 influenza 85.9 91.4 < .01
  Patient whose household member has suspected 2009 H1N1 influenza 61.5 80.2 < .0001
  Patient who provides care to patients and has an exposure 68.2 78.5 < .0001
  Patient who works as a teacher in an elementary school or day care and has an exposure 63.6 75.7 < .0001
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